Author

Daniela Pagliara Lage

Universidade Federal de Minas GeraisORCID 0000-0002-8710-9265Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Eduardo Antônio Ferraz CoelhoiD· 2 shared Haruna Luz Barazorda-CcahuanaiD· 2 shared Luis Daniel Goyzueta-MamaniiD· 2 shared Mayron Antonio Candia-PumaiD· 2 shared Miguel Á. Chávez‐FumagalliiD· 2 shared Alexsandro Sobreira GaldinoiD· 1 shared Camila Simões de FreitasiD· 1 shared E.L. D'AntonioiD· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Eduardo Antônio Ferraz CoelhoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Exploring the Potential of Malvidin and Echiodinin as Probable Antileishmanial Agents Through In Silico Analysis And In Vitro Efficacy

Luis Daniel Goyzueta-Mamani, Daniela Pagliara Lage, Haruna Luz Barazorda-Ccahuana, Margot Paco-Chipana, Mayron Antonio Candia-Puma, Gonzalo Dávila-Del-Carpio, Alexsandro Sobreira Galdino, Ricardo Andrez Machado‐de‐Ávila, Rodolfo Cordeiro Giunchetti, E.L. D'Antonio, Eduardo Antônio Ferraz Coelho, Miguel Á. Chávez‐Fumagalli

This study evaluates Malvidin and Echioidinin as antileishmanial agents through in vitro and in silico analyses, finding Malvidin more potent and less toxic than Echioidinin and Amphotericin B.

bioRxiv · Oct 4, 2024 · PreprintBioinformatics

In silico-based screening for natural products structural analogs as new drugs candidate against leishmaniasis

Haruna Luz Barazorda-Ccahuana, Luis Daniel Goyzueta-Mamani, Mayron Antonio Candia-Puma, Camila Simões de Freitas, Grasiele S.V. Tavares, Daniela Pagliara Lage, Eduardo Antônio Ferraz Coelho, Miguel Á. Chávez‐Fumagalli

This study identifies Malvidin as a potential drug candidate for leishmaniasis by screening natural product analogs using in silico methods targeting the parasite's arginase enzyme.

bioRxiv · Jul 22, 2022 · PreprintBioinformatics